Is BGMS or BIOA more undervalued in 2026?

CirclFi compares Bio Green Med Solution, Inc. (BGMS) and BioAge Labs, Inc. (BIOA) using 13 institutional-grade valuation models. BGMS has a Quality of Company score of 5.1/10 while BIOA scores 5.1/10.

Which is a better buy — BGMS or BIOA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BGMS and BIOA valuations compare?

BGMS at $1.10 and BIOA at $17.29 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BGMS vs BIOA Valuation Comparison 2026 — Intrinsic Value Analysis

BGMS

Pharmaceutical Preparations

Bio Green Med Solution, Inc.

Quality

5.1

out of 10

Value Trap

WARN

Price

$1.10

Last close

Models

11/13

Active

BIOA

Pharmaceutical Preparations

BioAge Labs, Inc.

Quality

5.1

out of 10

Value Trap

SAFE

Price

$17.29

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	BGMS Fair Value	BGMS Upside	BIOA Fair Value	BIOA Upside
Bayesian DCF	Intrinsic	$0.43	-60.5%	$7.24	-58.1%
Earnings Power Value	Intrinsic	$0.98	+0.1%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.39	-64.4%	$1.69	-89.9%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BGMS vs BIOA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BGMS vs BIOA — Which Stock Is More Undervalued?

BGMS scores higher with a 5.1/10 quality rating vs BIOA's 5.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Bio Green Med Solution, Inc. (BGMS) and BioAge Labs, Inc. (BIOA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BGMS currently trades at $1.10 with a QOC of 5.1/10, while BIOA trades at $17.29 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).